- Ask whether the prescription belongs under ordinary drug coverage.
- Ask whether the temporary program fits your situation.
- Check who can use it, which medicine counts, and what you pay.
The reason for treatment affects payment
Medicare Part D is the part that helps pay for medicine.
The body naturally makes a signal called GLP-1 that affects blood sugar and hunger. Semaglutide and tirzepatide are medicines that copy this signal.
At the September 26, 2026, check, ordinary Part D still did not cover medicines used solely for weight loss.
Medicare could pay for another medically accepted use, including treatment of type 2 diabetes. For adults with heart disease and excess body weight, certain medicines could also qualify to reduce the risk of a stroke or heart attack. The plan still had to check its payment rules.
Type 2 diabetes is an illness involving high blood sugar.
Ask your plan to check the exact medicine and why it was prescribed; another person’s coverage does not settle yours.
A temporary program is a separate path
Certain weight-care medicines have a temporary Medicare program called the GLP-1 Bridge. Its payments are separate from ordinary Part D. As checked September 26, 2026, it began on July 1, 2026, and ran through December 31, 2027.
For a covered medicine, each monthly supply cost $50 for people meeting the program’s rules.
That $50 was separate from your other Part D spending. It did not help you reach Part D’s yearly spending limit. The program gave no extra payment help to people on low incomes.
Coupons could not reduce the payment. Medicare’s prescription payment plan could not spread it over later months.
Keep this program’s payment on its own line in your cost list.
Check the age, weight, and health rules
As of September 26, 2026, you had to be 18 or older. Being 80 did not by itself rule you out.
BMI uses height and weight to produce a number. Ask the doctor to find the number from when you began the medicine.
Heart failure with preserved ejection fraction is a type of heart failure where the heart pumps out a normal share of blood with each beat. Pre-diabetes is blood sugar that is higher than normal but has not reached the diabetes range.
- A BMI of 35 or higher met the program’s weight rule without an extra illness from its list.
- A BMI of 30 or higher also needed a listed condition: kidney disease at stage 3a or worse, the heart-failure type called preserved ejection fraction, or blood pressure that was hard to control.
- With a BMI of 27 or higher, one listed condition was also needed: a previous stroke, pre-diabetes, a previous heart attack, or artery disease that caused symptoms in the limbs.
The doctor can check the kidney stage in your records. Blood-pressure readings use the unit mm Hg.
The blood-pressure rule applied despite treatment with two blood-pressure medicines: either the top reading was above 140 mm Hg, or the bottom reading was above 90 mm Hg.
These are program checks, not instructions to change treatment.
You needed a separate Part D medicine plan or a qualifying Medicare Advantage health plan with medicine coverage.
Ask your plan to confirm its type; not every Medicare Advantage plan counted.
The program needed a prescription and prior authorization, meaning approval before payment. It also required an ongoing food and physical-activity plan alongside the medicine.
Some health conditions use ordinary coverage instead
The program excluded type 2 diabetes, which belonged under ordinary Part D.
It also excluded moderate or severe obstructive sleep apnea, where a blocked airway repeatedly pauses breathing during sleep.
Another exclusion was the liver illness called MASH, with moderate or advanced scarring but without cirrhosis. MASH means liver inflammation linked to fat buildup; cirrhosis is severe liver scarring.
Ask the doctor and plan to check the exact diagnosis. A general description such as fatty liver is not enough to decide this rule.
You could not use the Bridge in 2026 if Part D had already paid for your GLP-1 prescription in 2026.
Check the name and form on the box
Only some products and forms counted.
As checked September 26, 2026, tirzepatide (Zepbound) counted only in the injection device named KwikPen. Its single-dose pens and vials did not count.
Look for KwikPen on the prescription and box. Ask the pharmacy to check the form before quoting the program price.